New research offers deeper insight into the body’s defense against harmful hemoglobin

CD163 might not be the most exciting name in the world, but behind it lies one of the body’s most important defence receptors, which steps in when red blood cells break down and release harmful haemoglobin. Now, researchers at Aarhus University are the first in the world to have mapped how CD163 functions.

27 March 2025 by Vibe Bregendahl Noordeloos

When infections such as malaria take hold in the body, red blood cells can be severely affected and risk breaking down. When that happens, haemoglobin is released into the bloodstream, potentially causing oxidative damage.

The damage occurs because cells are exposed to reactive oxygen molecules, which form in the bloodstream when oxygen comes into contact with free haemoglobin. If the body is exposed to excessive oxidative damage, it can cause blood vessel damage, kidney failure, inflammation, blood clots and cell death in vital organs.

Fortunately, the body has a rescue team at the ready. It consists of the blood protein haptoglobin, which binds to and neutralises haemoglobin, and the receptor CD163, which sits on the surface of macrophages. CD163’s role is to bind the haptoglobin-haemoglobin complex, which is then taken up by the macrophage and broken down inside the cell. But exactly how CD163 binds and takes up the haptoglobin-haemoglobin complex is something researchers have only just begun to understand.

Researchers at the Department of Biomedicine at Aarhus University are the first in the world to uncover the precise structure of CD163 bound to the haptoglobin-haemoglobin complex, providing unique insight into how the receptor functions.

This is not the first time Associate Professor Christian Brix Folsted Andersen and his research group have studied the body’s defence against haemoglobin, but this study digs a little deeper, he explains:

“We have previously described how the protein haptoglobin binds to haemoglobin and prevents it from causing damage in the bloodstream. What we see in our new research is how the unique structure of CD163 enables the body to effectively recognise, bind and take up the haptoglobin-haemoglobin complex. This is an important breakthrough because it connects earlier functional and structural observations.”

The research also opens up a broad range of opportunities, says Associate Professor Christian Brix Folsted Andersen:

“Now we can delve into how the structure and function of CD163 have evolved over time, and whether similar mechanisms exist in other species. At the same time, it may be relevant to analyse how CD163 interacts with other proteins and molecules in the body, and what factors regulate its activity.”

Behind the research - more information:

• Study method: Basic research
• Partners: Justin M. Kollman (University of Washington, USA), Jonas H. Graversen (University of Southern Denmark), Thomas Boesen (MBG, AU), Anders Etzerodt (AU), Søren K. Moestrup (AU)
• External funding: Lundbeck Foundation, Danish National Research Foundation
• Conflicts of interest: None
• Read more in the scientific article:https://www.nature.com/articles/s41467-024-55171-4

Contact

Associate Professor, PhD Christian Brix Folsted Andersen
Aarhus University, Department of Biomedicine
Phone: +45 30 26 48 55
Email: cbfa@biomed.au.dk